Eric D’Ortenzio

Eric D'Ortenzio is a medical doctor (M.D.), public health/epidemiology specialist in emerging infectious diseases and clinician in tropical medicine. He currently leads the Strategy and Partnerships Department at ANRS Emerging Infectious Diseases, a research agency of Inserm, where he drives scientific initiatives and strategic collaborations to address global health threats. Additionally, he serves on the board of the Global Health EDCTP3 partnership (EU-Africa) and is the scientific coordinator of AFROSCREEN project, a capacity-building project dedicated to genomic of emerging pathogens across Africa. He is also a clinician consultant in tropical medicine at the Bichat Hospital outpatient clinic in Paris (AP-HP).

With over 25 years of hands-on experience, Eric has worked in diverse settings across the globe—serving as a physician in France, the Central African Republic and French Guiana, a field coordinator for Médecins Sans Frontière in Côte d'Ivoire and Sudan, and an epidemiologist for Santé Publique France in Réunion Island. His leadership extends to heading the epidemiology research unit at the Institut Pasteur in New Caledonia and directing scientific efforts at the NGO Solthis. Prior to his current role, he was the scientific director of REACTing, an Inserm consortium focused on emerging infectious diseases.

Eric’s expertise spans primary healthcare, humanitarian aid, epidemic response, epidemiological surveillance, clinical research, and capacity building in resource-constrained environments. His contributions have been pivotal in shaping global public health strategies and interventions.

He holds an M.D. from the University of Aix-Marseille, with dual specialization in general medicine and public health and a Master Research Degree (MPH) in Epidemiology from Paris Sorbonne University along with advanced diplomas in tropical medicine and infectious diseases. He authored or co-authored more than 110 articles in international scientific journals on infectious diseases. 

In 2021, he was honored with the title of Chevalier de la Légion d'Honneur for his contributions to Covid-19 and global health.